穿刺总失败怎么办?试试这10种方法吧!

2019-01-24 佚名 护士学习笔记

静脉的成功率除与操作者娴熟的技术有关外,其稳定的情绪和良好的心理状态也是提高静脉的成功率的关键。

尝试一下新的穿刺手法吧!说不定,成功率更高!

1.扎两根止血带法

在肘关节上及腕关节内关穴处各扎一根止血带于肘窝部行静脉穿刺取血,比扎一根止血带效果好,对一些不能主动握拳配合的儿童,可代替握拳,同时局部血管充盈度满意。

此法不仅适合儿童,也适合成人中因消瘦、血管不固定、不充盈、肌张力低下、衰竭及无力握拳患者。并在此基础上,扩大到手背(止血带一根扎在腕关节内关穴处,另一根扎在2—5指的第一节指节处)、足背(止血带一根扎在踝关节的内踝上6cm处,另一根扎在足部1—5跖骨小头处)的静脉输液,对明显水肿及肥胖难以进行静脉穿刺的患者,用两根止血带,上下相距约15cm,捆扎肢体,1min后,松开下面一根止血带,这时该部位看到靛蓝色的静脉,利于穿刺。易

2.见回血法

一次性输液器的应用,存在着头皮针进入血管后,不易回血或回血量较少的缺点,影响静脉穿刺的成功率。易见回血的方法,一是调节器高调法,即调节器置于紧贴茂菲氏滴管下端,二是调节器高调输液瓶低位法,即调节器在高调的基础上,输液瓶挂于输液架调节旋钮上,成功率均高。

认为这两种方法,由于输液管内充满液体和液体瓶的位置降低,具有一定的虹吸作用;调节器置高位,输液管内承受回血的余地增加,所以头皮针一旦进入血管,血液就很容易回到针管内。

3.局部血管扩张法

(1)外涂血管扩张剂法:对周围静脉显露不明显,血管痉挛穿刺困难患者,用棉签蘸1%硝酸甘油涂在手背上,并湿热敷局部3min左右,表浅小静脉迅速充盈,经临床观察和仪器检测证实,此法能使静脉直径明显增加,血管充盈度增强,且无过敏反应发生。用棉签蘸阿托品注射液适量,涂擦穿刺局部皮肤8—12次,2—5min后,局部浅静脉扩张充盈显露,均未发生不良影响及后果,但婴幼儿、青光眼、心血管患者、高热抽搐、烦躁者慎用。用2%山莨菪碱,擦拭局部皮肤4下,对血管弹性差,脆性大,血管细,看不清,穿刺有困难患者,亦无不良反应产生。

(2)热敷法:局部热敷能使局部组织温度升高,改善血液循环,血管扩张,静脉充盈暴露。选用热敷局部穿刺法与常规穿刺法对创伤性和失血性休克患者进行了对比观察,结果穿刺成功率热敷法高于常规法。对指趾静脉穿刺、对小儿腹泻导致循环差,静脉塌陷,难以穿刺的患者,均主张配合热敷法,有助于提高穿刺的成功率。

4.非握拳穿刺法

常规法在行静脉穿刺时,嘱患者握拳,成功后才松拳。而在行手背静脉穿刺时,主张被穿刺手自然放置,护士用左手将患者的手固定成背隆掌空的握杯状手,这样可使血管突出于该部位、易于穿刺,另外嘱患者紧握拳,数秒钟再让其半握拳(拳心呈空虚状态),亦可嘱其反复握拳、松拳。采取反复握拳、松拳,能使指间肌肉收缩,促进血液向心回流,手背静脉充盈明显。

穿刺时握拳影响穿刺者的操作灵活性,且进针时针头与皮肤-、角度大,需将针头上挑,病人痛苦大,而且手背皮肤高度紧张,压迫血管致管腔变瘪-,进针后易穿透血管,再且血管被拉长,穿刺时若针尖斜面进入血管内较浅,松拳后,由于血管轻微回张,针尖斜面有可能部分或小部分脱出血管外,出现穿刺局部慢渗,胖大现象,而不握拳时上述现象较少见,减少了病人痛苦,提高了工作效率,值得推广运用。

5.穿破后的补救方法

对静脉穿刺时扎穿血管后,采用指压扎穿部位法止血进行补救,即扎穿血管后,针头缓慢往外撤,当有回血停止,立即指压扎穿部位,同时松开止血带,用1条胶布固定针柄。先以指重压1s左右,然后打开输液调节器,手指轻按以液体能缓慢通过为准,观察1min左右无外渗可停止按压,胶布固定针头,调整滴数。

认为此法特别适用于婴幼儿、老年人和不易寻找血管的患者。对此方法作了进一步的补充,即扎穿血管后,针头外撤有回血后,不应停止,还应将针头再前行少许,使针头超过扎穿部位,可避免渗漏。在作静脉穿刺时,输液针头应留1/4长度的针梗在皮肤外,才能实现穿破血管后加以补救。

6.进针角度的选择

教科书中静脉穿刺进针的角度为20°角,为达到了容易进针,提高穿刺成功率的目的,拒研究表明,一般病人穿刺可选择45°角或接近45°角进针;对老年浅小静脉穿刺,可选择35°角进针;对指(趾)背侧静脉穿刺,选择10°—15°角进针;对老年血管壁厚、硬、易滚动患者,选择超过40°角进针;对小儿头皮静脉、手背及足背浅静脉、指(趾)间静脉,选择10°—45°角进针,肘静脉、大隐、小隐静脉,选择20°—30°角进针。增大针头与皮肤之间的进针角度可减轻进针引起的疼痛或达到无痛注射,这与注射时皮肤所承受的压力、皮肤血管神经分布及皮肤结构特点有关。

7.无痛注射穿刺方法

皮肤痛觉神经纤维大多数分布于表皮,其痛觉感受器呈点状分布,在手背有触点25个,痛点100个—200个,所以VP时病人对疼痛非常敏感。经研究表明近尺侧的静脉穿刺时疼痛最轻,而近桡侧的静脉穿刺时疼痛最明显,这可能与神经分布、皮肤松弛及张力大小有关。减轻进针疼痛的方法还可以利用针尖刃面的锐度,穿刺时斜面略向左,减少针尖对组织的切割和撕拉,以达到减轻疼痛和减少组织损伤的目的。

8.逆行穿刺

对于长期输液、血管条件差、穿刺困难的病人,可充分利用四肢末梢血管,采用手足背静脉逆行穿刺法,其优点是回血好,滴数不受限制,不影响血流,可以弥补指掌关节向心穿刺不易固定的缺点,采用此法时必须选用手足背血管,而不应选择手指、足趾向上回血的小静脉,因此处无交通支,逆行穿刺将造成血液淤积,使穿刺失败。

9.固定方法

VP(静脉穿刺)时的固定方法是整个输液过程中的一个重要环节,根据力学、美学原理采用一侧滚动法较为规范,即先粘贴一侧皮肤,拉紧胶布至对侧皮肤,这样可使胶布处于紧张状态,保证不松动,妥善固定可防止针头刺穿静脉,还可阻止微生物被松动的针尖带进组织。

10.拔针方法

拔针时压迫穿刺处的手法不正确或压迫时间过短是造成皮下淤血的主要原因之一,皮下淤血后静脉显露不良,出血量大时血肿机化压迫血管,致使血管易与周围组织粘连,使该血管无法继续使用。因此正确拔针是保护远端周围静脉的重要措施之一。

拔针时应先将手指腹顺静脉走行平压在覆盖穿刺部位的小敷料上,压迫范围以穿刺点为中心,而且要大于穿刺点,针尖拔出后立即按压穿刺部位2min—5min,一般不致皮下淤血。在按压穿刺部位的同时拔出针尖则会引起局部疼痛或造成血管壁损伤。拔针时由于持针柄的方法不同,可引起不同的血管的损伤、疼痛反应及血管周围淤血等。

目前认为以拇指与示指持针柄的上下面拔针法明显优于拇指与示指持针柄的前后缘拔针法,二者差异有显着性,上下法在拔针时针柄固定,并施以相同的压力,可保持针尖在管腔内与之平行,明显减轻针刃对血管造成的机械性切割损伤。

静脉的成功率除与操作者娴熟的技术有关外,其稳定的情绪和良好的心理状态也是提高静脉的成功率的关键。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=359397, encodeId=6bd035939eb8, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jan 28 05:05:13 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311933, encodeId=723113119339f, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Sat Jan 26 12:38:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359171, encodeId=7ee83591e168, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/02/f667a67c6692f1e356c51a346d5b382f.jpg, createdBy=7b7a2515105, createdName=Janeinair, createdTime=Fri Jan 25 07:23:43 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359168, encodeId=492a35916853, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 25 06:57:14 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359164, encodeId=d906359164ff, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jan 25 06:22:40 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359160, encodeId=ebab35916000, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jan 25 00:23:13 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359152, encodeId=920e359152bf, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 24 22:45:19 CST 2019, time=2019-01-24, status=1, ipAttribution=)]
    2019-01-28 yjs木玉

    好好好好好好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=359397, encodeId=6bd035939eb8, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jan 28 05:05:13 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311933, encodeId=723113119339f, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Sat Jan 26 12:38:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359171, encodeId=7ee83591e168, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/02/f667a67c6692f1e356c51a346d5b382f.jpg, createdBy=7b7a2515105, createdName=Janeinair, createdTime=Fri Jan 25 07:23:43 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359168, encodeId=492a35916853, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 25 06:57:14 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359164, encodeId=d906359164ff, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jan 25 06:22:40 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359160, encodeId=ebab35916000, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jan 25 00:23:13 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359152, encodeId=920e359152bf, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 24 22:45:19 CST 2019, time=2019-01-24, status=1, ipAttribution=)]
    2019-01-26 rgjl
  3. [GetPortalCommentsPageByObjectIdResponse(id=359397, encodeId=6bd035939eb8, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jan 28 05:05:13 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311933, encodeId=723113119339f, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Sat Jan 26 12:38:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359171, encodeId=7ee83591e168, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/02/f667a67c6692f1e356c51a346d5b382f.jpg, createdBy=7b7a2515105, createdName=Janeinair, createdTime=Fri Jan 25 07:23:43 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359168, encodeId=492a35916853, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 25 06:57:14 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359164, encodeId=d906359164ff, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jan 25 06:22:40 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359160, encodeId=ebab35916000, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jan 25 00:23:13 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359152, encodeId=920e359152bf, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 24 22:45:19 CST 2019, time=2019-01-24, status=1, ipAttribution=)]
    2019-01-25 Janeinair

    有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=359397, encodeId=6bd035939eb8, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jan 28 05:05:13 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311933, encodeId=723113119339f, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Sat Jan 26 12:38:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359171, encodeId=7ee83591e168, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/02/f667a67c6692f1e356c51a346d5b382f.jpg, createdBy=7b7a2515105, createdName=Janeinair, createdTime=Fri Jan 25 07:23:43 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359168, encodeId=492a35916853, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 25 06:57:14 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359164, encodeId=d906359164ff, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jan 25 06:22:40 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359160, encodeId=ebab35916000, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jan 25 00:23:13 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359152, encodeId=920e359152bf, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 24 22:45:19 CST 2019, time=2019-01-24, status=1, ipAttribution=)]
    2019-01-25 txqjm

    谢谢了,学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=359397, encodeId=6bd035939eb8, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jan 28 05:05:13 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311933, encodeId=723113119339f, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Sat Jan 26 12:38:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359171, encodeId=7ee83591e168, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/02/f667a67c6692f1e356c51a346d5b382f.jpg, createdBy=7b7a2515105, createdName=Janeinair, createdTime=Fri Jan 25 07:23:43 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359168, encodeId=492a35916853, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 25 06:57:14 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359164, encodeId=d906359164ff, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jan 25 06:22:40 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359160, encodeId=ebab35916000, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jan 25 00:23:13 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359152, encodeId=920e359152bf, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 24 22:45:19 CST 2019, time=2019-01-24, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=359397, encodeId=6bd035939eb8, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jan 28 05:05:13 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311933, encodeId=723113119339f, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Sat Jan 26 12:38:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359171, encodeId=7ee83591e168, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/02/f667a67c6692f1e356c51a346d5b382f.jpg, createdBy=7b7a2515105, createdName=Janeinair, createdTime=Fri Jan 25 07:23:43 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359168, encodeId=492a35916853, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 25 06:57:14 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359164, encodeId=d906359164ff, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jan 25 06:22:40 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359160, encodeId=ebab35916000, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jan 25 00:23:13 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359152, encodeId=920e359152bf, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 24 22:45:19 CST 2019, time=2019-01-24, status=1, ipAttribution=)]
    2019-01-25 飛歌

    学习了很有用不错

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=359397, encodeId=6bd035939eb8, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Mon Jan 28 05:05:13 CST 2019, time=2019-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1311933, encodeId=723113119339f, content=<a href='/topic/show?id=21a6e54280e' target=_blank style='color:#2F92EE;'>#穿刺#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75428, encryptionId=21a6e54280e, topicName=穿刺)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8b48400, createdName=rgjl, createdTime=Sat Jan 26 12:38:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359171, encodeId=7ee83591e168, content=有用, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2019/01/02/f667a67c6692f1e356c51a346d5b382f.jpg, createdBy=7b7a2515105, createdName=Janeinair, createdTime=Fri Jan 25 07:23:43 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359168, encodeId=492a35916853, content=谢谢了,学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30331616752, createdName=txqjm, createdTime=Fri Jan 25 06:57:14 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359164, encodeId=d906359164ff, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Fri Jan 25 06:22:40 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359160, encodeId=ebab35916000, content=学习了很有用不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib3IzoRn621JdKCFUI4XvNELcibocrAVU6aUzEVDSaf3rYH08PUYUiagGqxAEhj8g9WqqNvD1CupIpCrmnR2OrqHZh/0, createdBy=7f181365728, createdName=飛歌, createdTime=Fri Jan 25 00:23:13 CST 2019, time=2019-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=359152, encodeId=920e359152bf, content=谢谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Thu Jan 24 22:45:19 CST 2019, time=2019-01-24, status=1, ipAttribution=)]
    2019-01-24 明月清辉

    谢谢分享,学习了

    0

相关资讯

昨天刚扎的留置针今天就堵了!怎么办?

“昨天刚扎的留置针,今天怎么就堵了?”,“留置针总是扎不进去,不是穿了就是没进血管“ ,临床工作的你,遇到过这种情况吗?为什么会发生这种情况呢?和这根针和谐相处,你可能需要了解这些......

这样的气胸不少见,胸腔穿刺需谨慎!

居然还有慢性气胸,你是在逗我么?

股静脉穿刺导丝滞留陷窝韧带与耻骨肌之间一例

患者,男,52岁。因“发热伴神志不清4h余”于2016年6月23日来我院就诊

郑州一医院被指将右肺穿刺手术做成左肺,涉事医生已被停职

郑州大学第一附属医院将一名患者的右肺穿刺手术做成左肺后,其家人提出十万元的赔偿要求。10月17日,医院方面回应记者称,已将涉事医生停职,等待下一步处理。目前,双方仍未就赔偿方案达成一致意见。穿刺手术做反,患方提出十万元赔偿张娜(化名)称,其母亲今年9月30日因肺炎住进郑州大学第一附属医院(以下简称“郑大一附院”)。经检查,医生提出对右肺一结节处做穿刺手术,检查该结节是良性还是恶性。张娜给记者提供

ARCH PATHOL LAB MED:细胞病理医师超声引导下细针穿刺与病理医师触诊引导下细针穿刺的比较

虽然病理学家已经建立细针穿刺(FNA),但它主要是通过手工触诊进行的。近年来,病理学家开始涉足超声引导FNAs (UGFNAs)。关于病理学家使用这种相对较新技术的经验的报告显示前景较好。然而,迄今为止,文献中很少有研究将病理学家进行的UGFNA与传统的病理学家进行触诊引导的FNA (PGFNA)进行比较。本研究的目的就是通过一个学术医学中心的细胞病理学家将UGFNA与PGFNA进行比较。由加州大

股动脉采血致大面积皮下血肿!动脉血标本采集要注意这些!

动脉采血在临床护理工作中经常会遇到,如何避免采血后并发症,您了解吗?